“Biogen Inc. BIIB announced two strategic collaborations to develop potential therapies for Alzheimer’s disease, Parkinson’s disease and other devastating neurological diseases.”
Read the full story at nasdaq.com
Biogen Inks Two Deals to Make Drugs for Neurological Diseases | NASDAQ
More from BusinessMore posts in Business »
- Biogen Stays the Wrong Course After a Key Drug Failure
- What Happened? Alzheon Leaves IPO on the Table for the Second Time | Biospace
- AC Immune inks $1.7bn deal with Lilly, strategic partnership with WuXi | Outsourcing Pharma
- BioXcel Announces Positive Data On Senile Dementia Of Alzheimer’s Type; Stock Up | NASDAQ
- Braincheck Raises Another $1.5 Million to Bring Artificial Intelligence to Dementia Care | PR Web